Showing results (31-40 of 53) with videos related to
Sort By:
Pageof 6
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|May 1, 1997
The effects of the 5-HT1A agonist flesinoxan, in three paradigms for assessing antidepressant potential in the ratJ F Cryan, A M Redmond, J P Kelly, et al.The Journal of Biological Chemistry|July 26, 1996
Identification and characterization of the protective hepatocyte erythrocyte protein 17 kDa gene of Plasmodium yoelii, homolog of Plasmodium falciparum exported protein 1D L Doolan, R C Hedstrom, W O Rogers, et al.The Indian Journal of Medical Research|August 1, 1997
DNA vaccines for malaria: the past, the present, & the futureD L Doolan, R C Hedstrom, R Wang, et al.Infection and Immunity|October 26, 1999
CD4(+) T-cell- and gamma interferon-dependent protection against murine malaria by immunization with linear synthetic peptides from a Plasmodium yoelii 17-kilodalton hepatocyte erythrocyte proteinY Charoenvit, V F Majam, G Corradin, et al.Journal of Pharmaceutical Sciences|December 1, 1996
DNA vaccines against malaria: immunogenicity and protection in a rodent modelM J Gardner, D L Doolan, R C Hedstrom, et al.The Journal of Experimental Medicine|December 1, 1994
Dominant selection of an invariant T cell antigen receptor in response to persistent infection by Epstein-Barr virusV P Argaet, C W Schmidt, S R Burrows, et al.Immunopharmacology|March 20, 1998
Acute 3,4-methylenedioxymethamphetamine(MDMA) administration produces a rapid and sustained suppression of immune function in the ratT J Connor, M G McNamara, D Finn, et al.Vaccine|June 1, 1997
Strategy for development of a pre-erythrocytic Plasmodium falciparum DNA vaccine for human useS L Hoffman, D L Doolan, M Sedegah, et al.Immunology and Cell Biology|August 1, 1997
Toward clinical trials of DNA vaccines against malariaS L Hoffman, D L Doolan, M Sedegah, et al.Journal of Immunology (Baltimore, Md. : 1950)|July 6, 2000
HLA-DR-promiscuous T cell epitopes from Plasmodium falciparum pre-erythrocytic-stage antigens restricted by multiple HLA class II allelesD L Doolan, S Southwood, R Chesnut, et al.Pageof 6